We report two cases of mosaic trisomy 16 diagnosed by amniocentesis, w
ith dysmorphic findings in both cases evident upon delivery. Following
elective termination, case 1 demonstrated a trisomy 16 cell line in f
etal skin (4 per cent) and placental tissue (64 per cent). Molecular s
tudies on the disomic cell line indicated that both chromosome 16s wer
e maternal in origin, suggesting loss of the paternal chromosome 16 fr
om a trisomic zygote (uniparental heterodisomy). At birth, case 2 demo
nstrated only disomic cells in skin and blood, with trisomy 16 present
in 4 per cent of cells from the amnion. Molecular studies confirmed b
oth maternal and paternal contributions of the chromosome 16s. We anal
ysed DNA from one previously reported case of mosaic trisomy 16 (Willi
ams et al., 1992) and failed to find signs of uniparental disomy in th
is child with congenital heart defects. These cases had distinctive bu
t different dysmorphic features. We suggest that trisomy 16 embryos ma
y revert to disomy during the course of pregnancy, allowing for longer
survival with various abnormalities in growth and morphogenesis. The
clinical significance of prenatally detected mosaic trisomy 16 may not
be completely defined by additional cytogenetic, molecular, and ultra
sound studies.